Author:
Diral Elisa,Catalano Gloria,Cicinelli Maria Vittoria,Distefano Andrea,Mastaglio Sara,Vago Luca,Lupo Stanghellini Maria Teresa,Bernardi Massimo,Ponzoni Maurilio,Ciceri Fabio,Carrabba Matteo G.
Abstract
Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a “watch and wait” strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.